Global Biopharmaceuticals Contract Manufacturing Market Size & Outlook
Global biopharmaceuticals contract manufacturing market, 2018-2030 (US$M)
Related Markets
Global biopharmaceuticals contract manufacturing market highlights
- The global biopharmaceuticals contract manufacturing market generated a revenue of USD 40,101.8 million in 2024 and is expected to reach USD 75,801.2 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 11.2% by 2030.
- In terms of segment, mammalian accounted for a revenue of USD 22,897.1 million in 2024.
- Non-mammalian is the most lucrative source segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, Norway is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 40,101.8 million |
| Market revenue in 2030 | USD 75,801.2 million |
| Growth rate | 11.2% (CAGR from 2024 to 2030) |
| Largest segment | Mammalian |
| Fastest growing segment | Non-mammalian |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Mammalian, Non-mammalian |
Other key industry trends
- In terms of revenue, the North America accounted for 34.3% of the global biopharmaceuticals contract manufacturing market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Norway is the fastest growing regional market and is projected to reach USD 347.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biopharmaceuticals Contract Manufacturing Market Scope
Biopharmaceuticals Contract Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Binex | View profile | 101-250 | Torrance, California, United States, North America | https://www.binexline.com |
| Cambrex | View profile | 1001-5000 | East Rutherford, New Jersey, United States, North America | http://www.cambrex.com |
| ADMA Biologics Inc | View profile | 624 | 465 State Route 17, Ramsey, NJ, United States, 07446 | https://www.admabiologics.com |
| Probiogen | View profile | 251-500 | Berlin, Berlin, Germany, Europe | http://www.probiogen.de |
| AGC Biologics | View profile | 1001-5000 | Bothell, Washington, United States, North America | http://www.agcbio.com/ |
| JRS Pharma | View profile | 11-50 | Rosenberg, Baden-Wurttemberg, Germany, Europe | http://jrspharma.com |
| Innovent Biologics Inc | View profile | 4872 | 168 Dongping Street, Suzhou Industrial Park, Jiangsu, Suzhou, China, People's Republic of, 215123 | https://www.innoventbio.com |
| Rentschler Biopharma SE | View profile | 501-1000 | Laupheim, Baden-Wurttemberg, Germany, Europe | https://www.rentschler-biopharma.com |
| Siegfried Holding AG | View profile | 4180 | Untere Bruehlstrasse 4, Zofingen, Switzerland, CH-4800 | https://www.siegfried.ch |
| Catalent Inc | View profile | 17219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | https://www.catalent.com |
| WuXi Biologics (Cayman) Inc | View profile | 12740 | No. 108, Meiliang Road, Mashan Binhu District, Wuxi, China, People's Republic of, 214092 | https://www.wuxibiologics.com |
| AGC Inc | View profile | 61671 | 1-5-1, Marunouchi, Chiyoda-ku, Tokyo, Japan, 100-8405 | https://www.agc.com |
| Toyobo Co Ltd | View profile | 12460 | 2-8, Dojima Hama 2-chome, Kita-ku, Osaka, Japan, 530-8230 | http://www.toyobo.co.jp |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Samsung Electronics Co Ltd | View profile | 124804 | 129, Samsung-ro, Yeongtong-gu, Gyeonggi-do, Suwon-si, Korea, Republic of, 443-742 | https://www.samsung.com |
| FUJIFILM Holdings Corp | View profile | 83784 | 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 | http://www.fujifilmholdings.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Global biopharmaceuticals contract manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceuticals contract manufacturing market will help companies and investors design strategic landscapes.
Mammalian was the largest segment with a revenue share of 57.1% in 2024. Horizon Databook has segmented the Global biopharmaceuticals contract manufacturing market based on mammalian, non-mammalian covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Biopharmaceuticals Contract Manufacturing Source Outlook (Revenue, USD Million, 2018-2030)
- Mammalian
- Non-mammalian
- Global Biopharmaceuticals Contract Manufacturing Service Outlook (Revenue, USD Million, 2018-2030)
- Analytical & QC Studies
- Process Development
- Upstream
- Downstream
- Fill & Finish Operations
- Packaging & Labelling
- Others
- Global Biopharmaceuticals Contract Manufacturing Drug Type Outlook (Revenue, USD Million, 2018-2030)
- Biosimilars
- Biologics
- Monoclonal Antibodies (mAbs)
- Vaccines
- Antisense, RNAi, & Molecular Therapy
- Recombinant Proteins
- Others
- Global Biopharmaceuticals Contract Manufacturing Type Outlook (Revenue, USD Million, 2018-2030)
- Drug Substance
- Finished Drug Product
- Global Biopharmaceuticals Contract Manufacturing Scale of Operation Outlook (Revenue, USD Million, 2018-2030)
- Clinical
- Commercial
- Global Biopharmaceuticals Contract Manufacturing Therapeutic Area Outlook (Revenue, USD Million, 2018-2030)
- Infectious Diseases
- Oncology
- Others
- Autoimmune Diseases
- Metabolic Diseases
- Cardiovascular Diseases
- Neurology
Reasons to subscribe to Global biopharmaceuticals contract manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global biopharmaceuticals contract manufacturing market databook
-
Our clientele includes a mix of biopharmaceuticals contract manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global biopharmaceuticals contract manufacturing market , including forecasts for subscribers. This global databook contains high-level insights into Global biopharmaceuticals contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global biopharmaceuticals contract manufacturing market size, by regions, 2018-2030 (US$M)
Top 10 countries: Biopharmaceuticals contract manufacturing market size, 2024 (US$M)
Global biopharmaceuticals contract manufacturing market share, by type, 2024 & 2030 (%, US$M)
Biopharmaceuticals contract manufacturing market: Opportunity assessment by country
Global biopharmaceuticals contract manufacturing market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
